In the present study, we observed that MSA treatment significantly down-regulated Keap1, induced nuclear accumulation of Nrf2 and enhance the antioxidant response element (ARE) promoter activity in ESCC cells. This evidence concerns the gene KEAP1 and esophageal squamous cell carcinoma.